Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2010 (2010), Article ID 590751, 7 pages
http://dx.doi.org/10.1155/2010/590751
Research Article

Brigham Fracture Intervention Team Initiatives for Hospital Patients with Hip Fractures: A Paradigm Shift

Departments of Orthopedic Surgery and Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA

Received 14 April 2009; Accepted 5 July 2009

Academic Editor: Diane Kamen

Copyright © 2010 Julie Glowacki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. L. Tosi and R. F. Kyle, “Fragility fractures: the fall and decline of bone health,” Journal of Bone and Joint Surgery. American Volume, vol. 87, no. 1, pp. 1–2, 2005. View at Publisher · View at Google Scholar
  2. F. D. Wolinsky, J. F. Fitzgerald, and T. E. Stump, “The effect of HIP fracture on mortality, hospitalization, and functional status: a prospective study,” American Journal of Public Health, vol. 87, no. 3, pp. 398–403, 1997. View at Google Scholar
  3. J. R. Center, D. Bliuc, T. V. Nguyen, and J. A. Eisman, “Risk of subsequent fracture after low-trauma fracture in men and women,” Journal of the American Medical Association, vol. 297, no. 4, pp. 387–394, 2007. View at Publisher · View at Google Scholar
  4. H. M. Schrøder, K. K. Petersen, and M. Erlandsen, “Occurrence and incidence of the second hip fracture,” Clinical Orthopaedics and Related Research, no. 289, pp. 166–169, 1993. View at Google Scholar
  5. C. Colón-Emeric, M. Kuchibhatla, C. Pieper et al., “The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies,” Osteoporosis International, vol. 14, no. 11, pp. 879–883, 2003. View at Publisher · View at Google Scholar
  6. The State of Healthcare Quality, “Industry Trends and Analysis. National Committee for Quality Assurance Health Plan Employer Data and Information Set,” November 2008, http://www.ncga.org/Portals/0/Newsroom/SOHC/SOHC_08.pdf.
  7. S. E. Andrade, S. R. Majumdar, K. A. Chan et al., “Low frequency of treatment of osteoporosis, among postmenopausal women following a fracture,” Archives of Internal Medicine, vol. 163, no. 17, pp. 2052–2057, 2003. View at Publisher · View at Google Scholar
  8. M. S. LeBoff, L. Kohlmeier, S. Hurwitz, J. Franklin, J. Wright, and J. Glowacki, “Occult vitamin D deficiency in postmenopausal US women with acute hip fracture,” Journal of the American Medical Association, vol. 281, no. 16, pp. 1505–1511, 1999. View at Publisher · View at Google Scholar
  9. D. G. Bruce, A. St John, F. Nicklason, and P. R. T. Goldswain, “Secondary hyperparathyroidism in patients from Western Australia with hip fracture: relationship to type of hip fracture, renal function, and vitamin D deficiency,” Journal of the American Geriatrics Society, vol. 47, no. 3, pp. 354–359, 1999. View at Google Scholar
  10. M. R. Baker, H. McDonnell, M. Peacock, and B. E. C. Nordin, “Plasma 25-hydroxy vitamin D concentrations in patients with fractures of the femoral neck,” British Medical Journal, vol. 1, no. 6163, p. 589, 1979. View at Google Scholar
  11. J. M. Pettifor, “Nutritional and drug-induced rickets and osteomalacia,” in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, M. J. Favus, Ed., pp. 399–407, American Society for Bone and Mineral Research, Washington, DC, USA, 2003. View at Google Scholar
  12. M. S. LeBoff, W. G. Hawkes, J. Glowacki, J. Yu-Yahiro, S. Hurwitz, and J. Magaziner, “Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures,” Osteoporosis International, vol. 19, no. 9, pp. 1283–1290, 2008. View at Publisher · View at Google Scholar
  13. J. Glowacki, M. S. LeBoff, N. S. Kolatkar, T. S. Thornhill, and M. B. Harris, “Importance of vitamin D in hospital-based fracture care pathways,” Journal of Nutrition, Health and Aging, vol. 12, no. 5, pp. 291–293, 2008. View at Publisher · View at Google Scholar
  14. C. F. Pieper, C. Colon-Emetic, J. Caminis et al., “Distribution and correlates of serum 25-hydroxyvitamin D levels in a sample of patients with Hip fracture,” American Journal Geriatric Pharmacotherapy, vol. 5, no. 4, pp. 335–340, 2007. View at Publisher · View at Google Scholar
  15. C. Simonelli, T. W. Weiss, J. Morancey, L. Swanson, and Y.-T. Chen, “Prevalence of vitamin D inadequacy in a minimal trauma fracture population,” Current Medical Research and Opinion, vol. 21, no. 7, pp. 1069–1074, 2005. View at Publisher · View at Google Scholar
  16. A. C. Looker and M. E. Mussolino, “Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults,” Journal of Bone and Mineral Research, vol. 23, no. 1, pp. 143–150, 2008. View at Publisher · View at Google Scholar
  17. H. A. Bischoff-Ferrari, E. J. Orav, and B. Dawson-Hughes, “Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial,” Archives of Internal Medicine, vol. 166, no. 4, pp. 424–430, 2006. View at Publisher · View at Google Scholar
  18. M. R. Brinker, D. P. O'Connor, Y. T. Monla, and T. P. Earthman, “Metabolic and endocrine abnormalities in patients with nonunions,” Journal of Orthopaedic Trauma, vol. 21, no. 8, pp. 557–570, 2007. View at Publisher · View at Google Scholar
  19. H. A. Bischoff-Ferrari, “The 25-hydroxyvitamin D threshold for better health,” Journal of Steroid Biochemistry and Molecular Biology, vol. 103, no. 3–5, pp. 614–619, 2007. View at Publisher · View at Google Scholar
  20. H. A. Bischoff-Ferrari, W. C. Willett, J. B. Wong, E. Giovannucci, T. Dietrich, and B. Dawson-Hughes, “Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials,” Journal of the American Medical Association, vol. 293, no. 18, pp. 2257–2264, 2005. View at Publisher · View at Google Scholar
  21. B. M. Tang, G. D. Eslick, C. Nowson, C. Smith, and A. Bensoussan, “Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis,” The Lancet, vol. 370, no. 9588, pp. 657–666, 2007. View at Publisher · View at Google Scholar
  22. J. E. Aaron, J. C. Gallagher, J. Anderson et al., “Frequency of osteomalacia and osteoporosis in fractures of the proximal femur,” The Lancet, vol. 1, no. 7851, pp. 229–233, 1974. View at Google Scholar
  23. L. D. Hordon and M. Peacock, “Osteomalacia and osteoporosis in femoral neck fracture,” Bone and Mineral, vol. 11, no. 2, pp. 247–259, 1990. View at Publisher · View at Google Scholar
  24. A. G. Need, M. Horowitz, H. A. Morris, R. Moore, and C. Nordin, “Seasonal change in osteoid thickness and mineralization lag time in ambulant patients,” Journal of Bone and Mineral Research, vol. 22, no. 5, pp. 757–761, 2007. View at Publisher · View at Google Scholar
  25. R. J. Petrella and T. J. Jones, “Do patients receive recommended treatment of osteoporosis following hip fracture in primary care?” BMC Family Practice, vol. 7, article 31, pp. e1–e6, 2006. View at Publisher · View at Google Scholar
  26. G. Hawker, R. Ridout, M. Ricupero, S. Jaglal, and E. Bogoch, “The impact of a simple fracture clinic intervention in improving the diagnosis and treatment of osteoporosis in fragility fracture patients,” Osteoporosis International, vol. 14, no. 2, pp. 171–178, 2003. View at Publisher · View at Google Scholar
  27. J. Vaile, L. Sullivan, C. Bennett, and J. Bleasel, “First Fracture Project: addressing the osteoporosis care gap,” Internal Medicine Journal, vol. 37, no. 10, pp. 717–720, 2007. View at Publisher · View at Google Scholar
  28. J. T. Harrington, H. L. Barash, S. Day, and J. Lease, “Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project,” Arthritis Care and Research, vol. 53, no. 2, pp. 198–204, 2005. View at Publisher · View at Google Scholar
  29. S. Bahl, P. S. Coates, and S. L. Greenspan, “The management of osteoporosis following hip fracture: have we improved our care?” Osteoporosis International, vol. 14, no. 11, pp. 884–888, 2003. View at Publisher · View at Google Scholar
  30. M. J. Gardner, K. R. Flik, P. Mooar, and J. M. Lane, “Improvement in the undertreatment of osteoporosis following hip fracture,” Journal of Bone and Joint Surgery. American Volume, vol. 84, no. 8, pp. 1342–1348, 2002. View at Google Scholar
  31. M. J. Gardner, R. H. Brophy, D. Demetrakopoulos et al., “Interventions to improve osteoporosis treatment following hip fracture: a prospective, randomized trial,” Journal of Bone and Joint Surgery. American Volume, vol. 87, no. 1, pp. 3–7, 2005. View at Publisher · View at Google Scholar
  32. E. A. Streeten, A. Mohamed, A. Gandhi et al., “The inpatient consultation approach to osteoporosis treatment in patients with a fracture: is automatic consultation needed?” Journal of Bone and Joint Surgery. American Volume, vol. 88, no. 9, pp. 1968–1974, 2006. View at Publisher · View at Google Scholar
  33. J. D. Kaufman, M. E. Bolander, A. D. Bunta, B. J. Edwards, L. A. Fitzpatrick, and C. Simonelli, “Barriers and solutions to osteoporosis care in patients with a hip fracture,” Journal of Bone and Joint Surgery. American Volume, vol. 85, no. 9, pp. 1837–1843, 2003. View at Google Scholar
  34. L. L. Tosi, R. Gliklich, K. Kannan, and K. J. Koval, “The american orthopaedic association's “own the bone” initiative to prevent secondary fractures,” Journal of Bone and Joint Surgery. American Volume, vol. 90, no. 1, pp. 163–173, 2008. View at Publisher · View at Google Scholar
  35. E. S. Siris, J. P. Bilezikian, M. R. Rubin et al., “Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 8, pp. 3482–3486, 2003. View at Publisher · View at Google Scholar
  36. B. J. Edwards, C. B. Langman, A. D. Bunta, M. Vicuna, and M. Favus, “Secondary contributors to bone loss in osteoporosis related hip fractures,” Osteoporosis International, vol. 19, no. 7, pp. 991–999, 2008. View at Publisher · View at Google Scholar
  37. N. M. Maalouf, H. J. Heller, C. V. Odvina, P. J. Kim, and K. Sakhaee, “Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature,” Endocrine Practice, vol. 12, no. 1, pp. 48–53, 2006. View at Google Scholar
  38. A. Barone, A. Giusti, G. Pioli et al., “Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial,” Journal of the American Geriatrics Society, vol. 55, no. 5, pp. 752–757, 2007. View at Publisher · View at Google Scholar
  39. E. F. Eriksen, K. W. Lyles, C. S. Colón-Emeric et al., “Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture,” Journal of Bone and Mineral Research, vol. 24, pp. 1308–1313, 2009. View at Google Scholar
  40. Y. Cao, S. Mori, T. Mashiba et al., “Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats,” Journal of Bone and Mineral Research, vol. 17, no. 12, pp. 2237–2246, 2002. View at Google Scholar
  41. N. Amanat, M. McDonald, C. Godfrey, L. Bilston, and D. Little, “Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair,” Journal of Bone and Mineral Research, vol. 22, no. 6, pp. 867–876, 2007. View at Publisher · View at Google Scholar